Evommune EVMN Increase Other Income Of Reimbursement
Increase Other Income Of Reimbursement at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:IncreaseOtherIncomeOfReimbursement.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's increase other income of reimbursement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Evommune 's increase other income of reimbursement?
- Evommune (EVMN) reported increase other income of reimbursement of $104.99K in Q4 2025.
- What does increase other income of reimbursement mean?
- Tracks the inflow of funds received as reimbursements for specific costs previously incurred by the company, such as research grants or shared development expenses. It serves as an indicator of external funding support or cost-sharing arrangements in clinical development.